Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306385536> ?p ?o ?g. }
- W4306385536 abstract "Recently, poly(ADP-ribosyl)ation polymerase inhibitors (PARPis), which induce synthetic lethality of tumor cells with DNA damage repair defects, have emerged as a promising therapy for ovarian, breast, and pancreatic cancer. Although the PARPi Olaparib is limited to treating cancer patients with DNA repair deficiencies, the PARPi Niraparib is FDA approved to treat ovarian cancer patients regardless of their status in DNA repair pathways. Despite differences in the affinity to PARP enzymes, the rationale behind the clinical use of Niraparib in patients without DNA repair deficiencies is still lacking. Moreover, only Olaparib has been approved for pancreatic ductal adenocarcinoma (PDAC) patients with BRCA mutations, accounting for only 5-7% of total PDACs. It remains unclear whether Niraparib could be beneficial to PDACs without BRCA mutations. We found that Niraparib inhibits ovarian and PDAC tumor cell growth, regardless of BRCA mutational status, more effectively than Olaparib. Unlike Olaparib, which is known to activate STAT3, Niraparib inhibits STAT3 activity in ovarian and PDAC cancer cell lines and patient tumors. Moreover, Niraparib regulates the expression of several STAT3 downstream genes involved in apoptosis. Overexpression of a constitutively activated STAT3 mutant rescues Niraparib-induced cancer cell apoptosis. Our results suggest that Niraparib inhibits pSTAT3 by interfering with SRC tyrosine kinase. Collectively, our studies provide a mechanism underlying Niraparib's ability to induce tumor cell apoptosis without BRCA mutations, suggesting the potential use of Niraparib for treating PDAC patients regardless of BRCA status." @default.
- W4306385536 created "2022-10-17" @default.
- W4306385536 creator A5001392090 @default.
- W4306385536 creator A5012334511 @default.
- W4306385536 creator A5021119678 @default.
- W4306385536 creator A5025468423 @default.
- W4306385536 creator A5026847104 @default.
- W4306385536 creator A5029466011 @default.
- W4306385536 creator A5030899790 @default.
- W4306385536 creator A5051087307 @default.
- W4306385536 creator A5067750617 @default.
- W4306385536 creator A5078914978 @default.
- W4306385536 creator A5079489540 @default.
- W4306385536 creator A5089509133 @default.
- W4306385536 date "2022-10-17" @default.
- W4306385536 modified "2023-09-25" @default.
- W4306385536 title "Niraparib-induced STAT3 inhibition increases its antitumor effects" @default.
- W4306385536 cites W1487052430 @default.
- W4306385536 cites W1548640328 @default.
- W4306385536 cites W1952507411 @default.
- W4306385536 cites W1993757260 @default.
- W4306385536 cites W1999608828 @default.
- W4306385536 cites W2003973314 @default.
- W4306385536 cites W2025340997 @default.
- W4306385536 cites W2026991540 @default.
- W4306385536 cites W2028544780 @default.
- W4306385536 cites W2032674547 @default.
- W4306385536 cites W2036988959 @default.
- W4306385536 cites W2044227662 @default.
- W4306385536 cites W2051631065 @default.
- W4306385536 cites W2052814975 @default.
- W4306385536 cites W2067117419 @default.
- W4306385536 cites W2074356752 @default.
- W4306385536 cites W2092606584 @default.
- W4306385536 cites W2098737737 @default.
- W4306385536 cites W2100525241 @default.
- W4306385536 cites W2102365935 @default.
- W4306385536 cites W2123145623 @default.
- W4306385536 cites W2125933228 @default.
- W4306385536 cites W2133591242 @default.
- W4306385536 cites W2168478794 @default.
- W4306385536 cites W2222817317 @default.
- W4306385536 cites W2226081785 @default.
- W4306385536 cites W2323969866 @default.
- W4306385536 cites W2514567198 @default.
- W4306385536 cites W2554085100 @default.
- W4306385536 cites W2597062310 @default.
- W4306385536 cites W2704877788 @default.
- W4306385536 cites W2883604786 @default.
- W4306385536 cites W2892812402 @default.
- W4306385536 cites W2895756789 @default.
- W4306385536 cites W2900248192 @default.
- W4306385536 cites W2903876972 @default.
- W4306385536 cites W2919508314 @default.
- W4306385536 cites W2947826965 @default.
- W4306385536 cites W2968820602 @default.
- W4306385536 cites W2975141952 @default.
- W4306385536 cites W3005516143 @default.
- W4306385536 cites W3006045662 @default.
- W4306385536 cites W3035510319 @default.
- W4306385536 cites W3036364440 @default.
- W4306385536 cites W3107163676 @default.
- W4306385536 cites W3119012248 @default.
- W4306385536 cites W3122695585 @default.
- W4306385536 cites W3156758253 @default.
- W4306385536 cites W3205011706 @default.
- W4306385536 cites W4200215809 @default.
- W4306385536 cites W4200444461 @default.
- W4306385536 cites W4206841660 @default.
- W4306385536 doi "https://doi.org/10.3389/fonc.2022.966492" @default.
- W4306385536 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36324587" @default.
- W4306385536 hasPublicationYear "2022" @default.
- W4306385536 type Work @default.
- W4306385536 citedByCount "0" @default.
- W4306385536 crossrefType "journal-article" @default.
- W4306385536 hasAuthorship W4306385536A5001392090 @default.
- W4306385536 hasAuthorship W4306385536A5012334511 @default.
- W4306385536 hasAuthorship W4306385536A5021119678 @default.
- W4306385536 hasAuthorship W4306385536A5025468423 @default.
- W4306385536 hasAuthorship W4306385536A5026847104 @default.
- W4306385536 hasAuthorship W4306385536A5029466011 @default.
- W4306385536 hasAuthorship W4306385536A5030899790 @default.
- W4306385536 hasAuthorship W4306385536A5051087307 @default.
- W4306385536 hasAuthorship W4306385536A5067750617 @default.
- W4306385536 hasAuthorship W4306385536A5078914978 @default.
- W4306385536 hasAuthorship W4306385536A5079489540 @default.
- W4306385536 hasAuthorship W4306385536A5089509133 @default.
- W4306385536 hasBestOaLocation W43063855361 @default.
- W4306385536 hasConcept C104317684 @default.
- W4306385536 hasConcept C121608353 @default.
- W4306385536 hasConcept C126322002 @default.
- W4306385536 hasConcept C134935766 @default.
- W4306385536 hasConcept C182979987 @default.
- W4306385536 hasConcept C2778502085 @default.
- W4306385536 hasConcept C2779962180 @default.
- W4306385536 hasConcept C2780427987 @default.
- W4306385536 hasConcept C502942594 @default.
- W4306385536 hasConcept C54355233 @default.
- W4306385536 hasConcept C71924100 @default.
- W4306385536 hasConcept C82381507 @default.